1. Home
  2. FGEN vs GROW Comparison

FGEN vs GROW Comparison

Compare FGEN & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • GROW
  • Stock Information
  • Founded
  • FGEN 1993
  • GROW 1968
  • Country
  • FGEN United States
  • GROW United States
  • Employees
  • FGEN N/A
  • GROW N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • GROW Investment Managers
  • Sector
  • FGEN Health Care
  • GROW Finance
  • Exchange
  • FGEN Nasdaq
  • GROW Nasdaq
  • Market Cap
  • FGEN 34.5M
  • GROW 32.9M
  • IPO Year
  • FGEN 2014
  • GROW N/A
  • Fundamental
  • Price
  • FGEN $0.52
  • GROW $2.42
  • Analyst Decision
  • FGEN
  • GROW
  • Analyst Count
  • FGEN 0
  • GROW 0
  • Target Price
  • FGEN N/A
  • GROW N/A
  • AVG Volume (30 Days)
  • FGEN 709.3K
  • GROW 30.5K
  • Earning Date
  • FGEN 02-24-2025
  • GROW 02-12-2025
  • Dividend Yield
  • FGEN N/A
  • GROW 3.70%
  • EPS Growth
  • FGEN N/A
  • GROW N/A
  • EPS
  • FGEN N/A
  • GROW 0.02
  • Revenue
  • FGEN $180,015,000.00
  • GROW $9,421,000.00
  • Revenue This Year
  • FGEN $21.91
  • GROW N/A
  • Revenue Next Year
  • FGEN N/A
  • GROW N/A
  • P/E Ratio
  • FGEN N/A
  • GROW $123.30
  • Revenue Growth
  • FGEN 16.15
  • GROW N/A
  • 52 Week Low
  • FGEN $0.18
  • GROW $2.38
  • 52 Week High
  • FGEN $2.80
  • GROW $2.95
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 53.72
  • GROW 43.91
  • Support Level
  • FGEN $0.46
  • GROW $2.43
  • Resistance Level
  • FGEN $0.51
  • GROW $2.49
  • Average True Range (ATR)
  • FGEN 0.04
  • GROW 0.04
  • MACD
  • FGEN -0.00
  • GROW -0.00
  • Stochastic Oscillator
  • FGEN 78.67
  • GROW 0.00

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

Share on Social Networks: